![]() |
市場調查報告書
商品編碼
2127883
乳房攝影影像市場規模、佔有率、成長、全球產業分析、區域趨勢及2026年至2034年預測Breast Imaging Market Size, Share, Growth and Global Industry Analysis, Regional Insights and Forecast to 2026-2034 |
||||||
全球乳房攝影影像市場到2025年達到60.3億美元,預計從2026年的66.6億美元成長到2034年的106.3億美元,預測期內CAGR為6.4%。北美地區引領全球市場,2025年佔據43.78%的市場佔有率,這主要得益於該地區較高的篩檢意識、先進的醫療基礎設施以及數位乳房攝影影像技術的廣泛應用。
乳房攝影影像在乳癌的早期發現、診斷和後續觀察中發揮著非常重要的作用。現代影像技術包括2D乳房乳房X光攝影、數位乳房斷層合成(3D乳房X光攝影)、乳房磁振造影、乳房超音波、分子乳房攝影影像、人工智慧輔助診斷軟體。乳癌發生率的上升、政府篩檢計畫的擴大、技術的進步以及人們對早期診斷意識的提高,持續推動全球對先進乳房攝影影像系統的需求。
市場趨勢
乳房攝影影像市場最顯著的趨勢之一是從傳統的2D乳房乳房X光攝影轉向3D數位乳房斷層合成、造影乳房X光攝影和人工智慧成像。這些先進技術提高了病灶檢出的準確性,減少了組織重疊,增強了診斷可靠性,並最大限度地減少了不必要的重複檢查。
人工智慧(AI)正日益融入乳房攝影影像工作流程,輔助放射科醫師評估乳房密度、偵測病灶、評估風險並快速解讀影像。製造商不斷推出創新影像系統,這些系統具有更高的影像品質、更自動化的工作流程和更高的臨床效率。
市場促進因素
乳癌發生率的上升仍然是市場成長的主要驅動力。人們對早期診斷和定期篩檢的認知不斷提高,導致對乳房X光攝影系統、乳房核磁共振成像、超音波和其他先進成像技術的需求顯著成長。
根據本報告,美國癌症協會估計,到2026年1月,美國將新增約382,640例乳癌病例,凸顯了對高效篩檢和診斷解決方案日益成長的需求。各國政府、醫療機構和診斷中心正不斷擴大篩檢項目,以提高早期發現率和改善患者預後,進一步推動市場成長。
市場限制因素
儘管需求不斷成長,但高昂的設備成本仍然是市場滲透的一大障礙,尤其是在開發中國家和小規模醫療機構。諸如數位乳房斷層合成、乳房磁振造影、造影增強乳房X光攝影和人工智慧系統等先進影像技術,不僅需要大量的資金投入,還需要持續的維護成本。
此外,患者對輻射暴露和乳房X光攝影帶來的不適的擔憂也降低了他們參與定期篩檢計畫的動機。另外,成本效益仍然是預算有限的醫療機構面臨的一大障礙。
市場機會
人工智慧(AI)與工作流程自動化的整合為市場參與企業帶來了巨大的機會。人工智慧驅動的軟體透過支援自動病灶檢測、乳房密度分析、風險預測和更快的影像解讀,改善放射科的工作流程。
醫療影像公司與技術供應商之間的合作加速人工智慧的應用。這些創新幫助醫療機構提高診斷準確率,減輕放射科醫生的工作量,並更有效地管理日益增多的篩檢工作。
市場挑戰
乳房攝影市場面臨的一大挑戰是訓練有素的放射科醫生和放射技師短缺。先進的影像系統需要技術嫻熟的專業人員進行精準的影像擷取與解讀。許多國家持續面臨人員短缺問題,導致診斷延誤,並限制了乳房篩檢服務的可近性,尤其是在服務不足的地區。
市場區隔
依影像方法分類,由於2D乳房X光攝影的廣泛應用、價格親民以及醫院和篩檢項目中完善的保險償付政策,到2025年,2D乳房X光攝影將佔據最大的市場佔有率。然而,由於其卓越的診斷能力,數位乳房斷層合成成像領域預計將在預測期內實現最快的成長。
依技術分類,到2025年,基於電離輻射的乳房攝影主導市場,並有望保持其主導地位,這主要得益於數位乳房X光攝影和斷層合成技術在乳癌篩檢中的日益普及。非電離輻射成像領域,包括乳房磁振造影和超音波,預計也將實現強勁成長。
就終端用戶而言,醫院在2025年仍是主要用戶群體,這主要得益於其龐大的患者群體、較高的投資能力以及先進的診斷影像基礎設施。此外,受門診篩檢服務成長的推動,診斷影像中心也快速擴張。
北美仍是最大的區域市場,到2025年市場規模達到26.4億美元。慷慨的保險償付計劃、較高的乳癌篩檢意識以及3D乳房X光攝影系統的廣泛應用,持續推動該地區的成長。預計到2026年,美國市場規模將達到26.5億美元,約佔全球整體銷售額的41.1%。
由於完善的醫療保健體系和全國性的系統篩檢項目,歐洲預計將繼續保持第二大市場地位,到2026年市場規模將達到 14.9億美元。德國和英國將繼續大力投資先進的乳房攝影成像技術。
預計到2026年,亞太地區乳癌市場規模將達到13.2億美元,主要成長動力來自人們對乳癌認知的提高、醫療基礎設施的不斷完善以及數位乳房X光攝影系統的廣泛應用。中國、日本和印度由於擁有龐大的患者群體和不斷提升的診斷能力,預計仍將是關鍵的成長市場。
在拉丁美洲、中東和非洲,隨著各國政府擴大乳癌篩檢計劃,私人診斷中心繼續投資數位影像設備,乳癌篩檢業務逐步成長。
The global breast imaging market was valued at USD 6.03 billion in 2025 and is projected to grow from USD 6.66 billion in 2026 to USD 10.63 billion by 2034, registering a CAGR of 6.4% during the forecast period. North America dominated the global market with a 43.78% market share in 2025, supported by high screening awareness, advanced healthcare infrastructure, and widespread adoption of digital breast imaging technologies.
Breast imaging plays a critical role in the early detection, diagnosis, and monitoring of breast cancer. Modern imaging technologies include 2D mammography, digital breast tomosynthesis (3D mammography), breast MRI, breast ultrasound, molecular breast imaging, and AI-assisted diagnostic software. The growing prevalence of breast cancer, increasing government screening initiatives, technological advancements, and rising awareness regarding early diagnosis continue to drive demand for advanced breast imaging systems worldwide.
Market Trends
One of the most significant trends in the breast imaging market is the transition from conventional 2D mammography to 3D digital breast tomosynthesis, contrast-enhanced mammography, and AI-supported image interpretation. These advanced technologies improve lesion detection, reduce tissue overlap, and enhance diagnostic confidence while minimizing unnecessary recalls.
Artificial intelligence is becoming increasingly integrated into breast imaging workflows by assisting radiologists in breast density assessment, lesion detection, risk evaluation, and faster interpretation. Manufacturers are continuously introducing innovative imaging systems featuring improved image quality, automated workflows, and enhanced clinical efficiency.
Market Drivers
The rising incidence of breast cancer remains the primary factor driving market growth. Increasing awareness regarding early diagnosis and routine screening has significantly increased the demand for mammography systems, breast MRI, ultrasound, and other advanced imaging technologies.
According to the report, the American Cancer Society estimated approximately 382,640 new breast cancer cases in the U.S. in January 2026, highlighting the growing need for efficient screening and diagnostic solutions. Governments, healthcare providers, and diagnostic centers continue expanding screening programs to improve early detection and patient outcomes, further supporting market expansion.
Market Restraints
Despite growing demand, high equipment costs continue to limit market penetration, particularly in developing countries and smaller healthcare facilities. Premium imaging technologies such as digital breast tomosynthesis, breast MRI, contrast-enhanced mammography, and AI-enabled systems require significant capital investment as well as ongoing maintenance costs.
Patient concerns regarding radiation exposure and discomfort associated with mammography procedures also reduce participation in regular screening programs. Additionally, affordability remains a major barrier for healthcare providers operating under limited budgets.
Market Opportunities
The integration of artificial intelligence and workflow automation presents substantial opportunities for market participants. AI-powered software is improving radiology workflows by supporting automated lesion detection, breast density analysis, risk prediction, and faster image interpretation.
Collaborations between imaging companies and technology providers continue to accelerate AI adoption. These innovations are helping healthcare organizations improve diagnostic accuracy, reduce radiologist workload, and manage increasing screening volumes more efficiently.
Market Challenges
A major challenge facing the breast imaging market is the shortage of trained radiologists and imaging technologists. Advanced imaging systems require skilled professionals for accurate image acquisition and interpretation. Many countries continue to experience workforce shortages, delaying diagnosis and limiting access to breast screening services, particularly in underserved regions.
Market Segmentation
Based on imaging modality, 2D mammography accounted for the largest market share in 2025 due to its extensive installed base, affordability, and established reimbursement policies across hospitals and screening programs. However, the digital breast tomosynthesis segment is expected to witness the fastest growth during the forecast period owing to its superior diagnostic capabilities.
By technology, ionizing breast imaging dominated the market in 2025 and is expected to maintain its leadership due to the widespread use of digital mammography and tomosynthesis in breast cancer screening. The non-ionizing imaging segment, including breast MRI and ultrasound, is also expected to experience healthy growth.
Among end users, hospitals remained the leading segment in 2025 because of higher patient volumes, greater investment capacity, and access to advanced imaging infrastructure. Diagnostic imaging centers are also expanding rapidly due to increasing outpatient screening services.
North America remained the largest regional market with a valuation of USD 2.64 billion in 2025. Strong reimbursement policies, high awareness of breast cancer screening, and widespread deployment of 3D mammography systems continue to support regional growth. The U.S. market is projected to reach USD 2.65 billion in 2026, accounting for approximately 41.1% of global revenues.
Europe is expected to remain the second-largest market, reaching USD 1.49 billion in 2026, supported by well-developed healthcare systems and organized national screening programs. Germany and the U.K. continue to invest heavily in advanced breast imaging technologies.
Asia Pacific is projected to reach USD 1.32 billion in 2026, driven by increasing breast cancer awareness, expanding healthcare infrastructure, and growing adoption of digital mammography systems. China, Japan, and India are expected to remain key growth markets due to their large patient populations and improving diagnostic capabilities.
Latin America and the Middle East & Africa are also witnessing gradual growth as governments expand breast cancer screening programs and private diagnostic centers continue investing in digital imaging equipment.
Competitive Landscape
The breast imaging market remains highly competitive, with innovation focused on AI-assisted diagnosis, advanced mammography systems, and improved imaging workflows. Leading companies continue expanding their product portfolios through technological innovation, strategic collaborations, acquisitions, and geographic expansion.
Major companies operating in the market include Hologic, Inc., GE HealthCare, Siemens Healthineers AG, FUJIFILM Holdings Corporation, Koninklijke Philips N.V., Canon Inc., Shanghai United Imaging Healthcare Co., LTD, Planmed Oy, IMS Giotto S.p.A., and Metaltronica S.p.A.
Key Industry Developments
Several strategic developments are strengthening market growth. In November 2025, GE HealthCare received FDA approval for its AI-powered Pristina Recon DL 3D mammography reconstruction application. ScreenPoint Medical was selected for the USD 16.0 million PRISM randomized clinical trial in September 2025. In April 2025, SimonMed partnered with Lunit and Volpara to expand AI-powered breast cancer detection across its imaging network. Earlier, Siemens Healthineers obtained FDA approval for the MAMMOMAT B.brilliant tomosynthesis platform, while GE HealthCare launched its MyBreastAI Suite to enhance AI-driven mammography interpretation.
Conclusion
The breast imaging market is expected to experience steady growth as healthcare systems worldwide continue prioritizing early breast cancer detection and advanced diagnostic technologies. Rising adoption of 3D mammography, AI-powered imaging solutions, workflow automation, and digital screening platforms will continue transforming breast cancer diagnosis. With the market expanding from USD 6.03 billion in 2025 to USD 6.66 billion in 2026 and projected to reach USD 10.63 billion by 2034, ongoing technological innovation, expanding screening programs, and increasing awareness of early diagnosis will remain the primary drivers supporting long-term market growth.
Segmentation By Imaging Modality, Technology, End-user, and Region
By Imaging Modality * 2D Mammography
By Technology * Ionizing Breast Imaging
By End-user * Hospitals
By Region * North America (By Imaging Modality, Technology, End-user, and Country)